World's Best Scientists 2026 revealed!
Clinical Nuclear Medicine
H-index 21

Clinical Nuclear Medicine

0363-9762

Published by: Lippincott Williams & Wilkins

https://journals.lww.com/nuclearmed/pages/default.aspx

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1410 128 160 17

Additional Metrics

Number of Best Scientists*: 229
Documents by Best Scientists*: 320
Top 100 Ranked Scientists*: 6
SCIMAGO H-index: 73
SCIMAGO SJR: 0.653
Impact Factor: 9.6

Overview

Top Research Topics at Clinical Nuclear Medicine?

Clinical Nuclear Medicine generally zeroes in on subjects such as Radiology, Nuclear medicine, Pathology, Scintigraphy and Internal medicine. It connects the study in Radiology with the closely related area of Lesion. Nuclear medicine research featured in Clinical Nuclear Medicine incorporates concerns from various other topics such as Tomography, Magnetic resonance imaging and Perfusion.

In the journal, Lung, Metastasis and Thyroid are investigated in conjunction with one another to address concerns in Pathology research. It explores issues in Scintigraphy which can be linked to other research areas like Technetium, Surgery and Bone scintigraphy. The journal explores topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology, Endocrinology, Oncology and Cardiology.

The journal features studies on Positron emission tomography, including topics such as Fluorodeoxyglucose. Most of the works presented in the journal deals with PET-CT but it intersects with the subject of Prostate cancer.

  • Radiology (41.91%)
  • Nuclear medicine (24.14%)
  • Pathology (22.97%)

What are the most cited papers published in the journal?

  • Radioactive and Stable Isotope Tracers in Biomedicine (359 citations)
  • Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. (227 citations)
  • F-18 FDG uptake in the large arteries: a new observation. (215 citations)

Research areas of the most cited articles at Clinical Nuclear Medicine:

Radiology, Nuclear medicine, Positron emission tomography, Pathology and Scintigraphy are the main subjects of interest in the published articles. The featured Radiology studies in the journal papers mainly concentrate on Carcinoma but also cover areas of interest in Lung cancer. The most cited publications focus on Nuclear medicine but the discussions also offer insight into other areas such as Magnetic resonance imaging and Radiation therapy.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Radiology
  • Surgery

The previous edition focused in particular on these issues:

Clinical Nuclear Medicine aims to foster the development of research in Radiology, PET-CT, Pathology, Fdg pet ct and Nuclear medicine. Clinical Nuclear Medicine explores research in Metastasis and overlapping concepts in Lung to expand the discourse in Radiology. Some problems in PET-CT that were presented in the journal overlapped with concepts under 68ga psma and Prostate cancer, Glutamate carboxypeptidase II.

Biochemical recurrence and Prostatectomy are among the concentrations of Prostate cancer that garnered much attention in it. In the Pathology research discussed, Malignancy, Pathological and Differential diagnosis are all tackled. Clinical Nuclear Medicine focuses on Fdg pet ct but the discussions also offer insight into other areas such as Fdg uptake, Chemotherapy and Lymphoma.

The most cited articles from the last journal are:

  • Feasibility of Deep Learning-Guided Attenuation and Scatter Correction of Whole-Body 68Ga-PSMA PET Studies in the Image Domain. (11 citations)
  • The American College of Nuclear Medicine Guidance on Operating Procedures for a Nuclear Medicine Facility During COVID-19 Pandemic. (11 citations)
  • COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT. (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical Nuclear Medicine (based on the number of publications) are:

  • Richard P. Spencer (240 papers) absent at the last edition,
  • Abass Alavi (170 papers) absent at the last edition,
  • Jay A. Harolds (150 papers) published 15 papers at the last edition, 8 less than at the previous edition,
  • Hongming Zhuang (129 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Chia-Hung Kao (126 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical Nuclear Medicine (based on the number of publications) are:

  • All India Institute of Medical Sciences (174 papers) published 20 papers at the last edition, 1 more than at the previous edition,
  • University of Southern California (162 papers) published 4 papers at the last edition, 6 less than at the previous edition,
  • Michigan State University (145 papers) published 15 papers at the last edition, 8 less than at the previous edition,
  • Mayo Clinic (138 papers) published 5 papers at the last edition, 1 less than at the previous edition,
  • Peking Union Medical College Hospital (119 papers) published 18 papers at the last edition, 8 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 24.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.07% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.68% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.44% of all publications and 66.80% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

A Career in Clinical Nuclear Medicine

For those interested in a career in this unique branch of medicine, the possibilities are abundant. Clinical nuclear medicine is a multifaceted field that focuses on the use of radioactive substances in diagnosing and treating disease. This specialty is often involved in a full range of disciplines such as radiology, internal medicine, pathology, and more. Therefore, future practitioners in this field need to be well-trained in these areas. There is a wide array of opportunities for professionals interested in the field. These individuals could work in hospitals, private practice, research institutions, or universities. A career in nuclear medicine offers the chance to apply leading-edge medical technology to deliver intricate patient care. Besides, professionals in this field have the opportunity to constantly engage with innovative research topics, as highlighted throughout this article. To start a rewarding career in nuclear medicine, aspiring individuals can follow specific academic and career paths. A comprehensive guide on how to commence a career in this area, including essential educational requirements, internship opportunities, certification processes, and job prospects, could be instrumental for aspiring professionals. For those looking to start a nursing career in Texas, for instance, they can find more details on how to proceed by visiting how to become a nurse in Texas. A career in this rapidly advancing field not only offers diverse opportunities but also has the potential to significantly impact patient’s lives through improved diagnostic and therapeutic techniques. Those who choose to follow a career path in clinical nuclear medicine will have the opportunity to constantly broaden their knowledge and professional capacities while making significant contributions to the field of medicine.

Top Publications

  • Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.

    Pierre Sesques;Jérémie Tordo;Emmanuelle Ferrant;Violaine Safar

    (2021)
    40 Citations
  • Potential and Most Relevant Applications of Total Body PET/CT Imaging.

    (2022)
    39 Citations
  • Sentinel node imaging and radioguided surgery in the era of SPECT/CT and PET/CT: Toward new interventional nuclear medicine strategies

    Renato Alfredo Valdés Olmos;Daphne D D Rietbergen;Domenico Rubello;Lenka M Pereira Arias-Bouda

    (2020)
    34 Citations
  • Two Tumors, One Target: Preliminary Experience With 90Y-FAPI Therapy in a Patient With Metastasized Breast and Colorectal Cancer.

    Hendrik Rathke;Stefan Fuxius;Frederik L Giesel;Thomas Lindner

    (2021)
    31 Citations
  • Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI.

    Angelika M Starzer;Anna S Berghoff;Tatjana Traub-Weidinger;Alexander R Haug

    (2021)
    31 Citations
  • Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination

    (2021)
    29 Citations
  • Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors.

    Alessio Annovazzi;Sabrina Vari;Diana Giannarelli;Rosella Pasqualoni

    (2020)
    27 Citations
  • The Imaging Features and Clinical Associations of a Novel Tau PET Tracer-18F-APN1607 in Alzheimer Disease.

    Jung-Lung Hsu;Kun-Ju Lin;Ing-Tsung Hsiao;Kuo-Lun Huang

    (2020)
    24 Citations
  • Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up.

    Sonia Mahajan;Reiko Nakajima;Mariko Yabe;Ahmet Dogan

    (2020)
    24 Citations
  • The Concept of Strength Through Synergy Applied to the Search of Powerful Prognostic Biomarkers in Gastroesophageal Cancer: An Example Based on Combining Clinicopathological Parameters, Imaging-Derived Sarcopenia Measurements, and Radiomic Features.

    (2022)
    24 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but exploring alternatives to traditional medical degrees, several online programs offer practical and rewarding career options. One affordable pathway is pursuing a low cost medical coding and billing online program. This field focuses on translating healthcare services into standardized codes for insurance and billing purposes, making it a vital role in healthcare administration.

Nursing remains a popular and accessible option for many. Exploring options such as what is the easiest nursing school to get into can help prospective students find schools with supportive admission processes and suitable programs. Nursing careers offer strong job security and opportunities for specialization.

For those interested in leadership roles within healthcare, an online degree is a flexible way to gain relevant skills. The healthcare administration online degree programs emphasize management and operational aspects of healthcare institutions, preparing graduates to lead effectively.

Similarly, pursuing an online health management degree offers a cost-effective route to develop expertise in managing healthcare systems and policies, enhancing career prospects in an evolving industry.

Best Scientists Contributing to This Journal

Recently Published Articles